Policy

The laws, regulations, strategies, and governance frameworks that guide how governments and institutions address substance use, substance use disorders, and illicit drug trafficking. These policies shape coordinated responses across prevention, treatment, recovery support, public health, regulatory control, and law enforcement. Effective substance use policies aim to reduce health and social harms, ensure access to prevention and treatment services, regulate controlled substances, and disrupt illicit drug markets. They are typically informed by scientific evidence, public health principles, and cross-sector collaboration to promote safer and healthier communities. 

Stigma Reading List

Reading List
Stigma is a complex construct that is present within societies at different levels. The impact of stigma can severely damage individuals and communities. People who use substances are often on the receiving end of stigmatising attitudes and...

Measuring Organized Crime in the Western Balkans

Book
Executive Summary The findings of this report are based on a statistical and analytical framework to measure and assess organized crime in the Western Balkans. Six countries and territories are included: Albania, Bosnia and Herzegovina...

Let's Talk E-cigarettes

Website
Since coming on the market over a decade ago, e-cigarettes have divided opinion. A team of Oxford researchers are searching for new e-cigarette studies every month. In this podcast, Dr Jamie Hartmann-Boyce and Dr Nicola Lindson talk about...

Global Alcohol Policy Alliance Virtual Event 2021

Event Date
 - 
Online

The Global Alcohol Policy Alliance Virtual Event 2021 will be held 12-14 October 2021, in the same week that was originally planned for GAPC 2021. While GAPC has been postponed to 2023, the GAPA Virtual Event will offer interactive sessions in different time zones.

EMCDDA Technical Report on New Psychoactive Substance

Book
The purpose of this technical report is to provide an analysis of the available information on methyl 2-{[1-(4-fluorobutyl)-1 H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (commonly known as 4F-MDMB-BICA), a synthetic receptor...